Occult hepatitis B virus infection status is not associated with impaired efficacy of anti-CD19 CAR-T-cell therapy for lymphoma and shows a distinct immune toxicity profile: Results from the CART-SIE study.
来源：PubMed发布日期：2026-05-01作者：Polverelli N, Chiappella A, Carniti C, Zinzani P, Musso M0 次点击